Transduced DCs, which have been rendered insensitive to TGF-β, maintain their normal phenotype, present upregulated expression of surface costimulatory molecules (CD80/CD86) and induce potent tumor-specific cytotoxic T lymphocyte responses in vivo [150]. The gene discussed is CD80; the disease is neoplasm.